Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) currently has a daily average trading volume of 5.38M but it saw 207736834 shares traded in last market. With a market cap of 2.62M USD, the company’s current market price of $0.29 came rising about 38.23 while comparing to the previous closing price of $0.21. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.57 and as low as $0.21. In the recent trading on the day, stock has struck highest price mark of $0.2469 while lowest mark touched by it was $0.42.
Taking a look at 20-day trading activity of Quoin Pharmaceuticals Ltd ADR (QNRX) gives us an average price of $0.2857, while its current price level is -81.37% below from 52-week high level whereas it is 38.23% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3120 while that of 200 days or SMA-200 reads an average of $0.5480. A closer look into the stock’s movement over the week reveals that its volatility is standing at 24.47% during that period while stretching the period over a month that decreases to 11.52%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 49.51 which implies that the stock is in neutral territory.
Over the week, QNRX’s stock price is moving -0.85% down while it is -0.85% when we observe its performance for the past one month. Year-to-date it is -55.05% down and over the past year, the stock is showing a downside performance of -68.88%.
The company is expected to be releasing its next quarterly report on 2025-Mar-12, for which analysts forecasted an EPS of -0.12 while estimate for next year EPS is -0.5.
Currently, Quoin Pharmaceuticals Ltd ADR’s total number of outstanding shares is 8.95M with 7.08% of that held by the insiders while 7.51% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -97.85% and return on equity (ROE) at -121.15%. Stock’s beta reads 1.39. Stock has a price to book (P/B) ratio of 0.28. Its return on asset (ROA) is -64.61% on average.
